Yoshitsugu Miyazaki, n/a

Director
National Institute of Infectious Diseases, Japan

Disclosure(s): No financial relationships to disclose

Poster(s):

• 1128 - Efficacy and Safety of Nelfinavir in Asymptomatic and Mild COVID-19 Patients: A Multicenter, Randomized Controlled Trial
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET